4.7 Article

Glioblastoma Treatment: Bypassing the Toxicity of Platinum Compounds by Using Liposomal Formulation and Increasing Treatment Efficiency With Concomitant Radiotherapy

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ijrobp.2011.10.054

关键词

Platinum compounds; Liposomes; Gamma radiation; F98 glioma; Fischer rats

资金

  1. Canadian Institutes of Health Research [MOP 81356]
  2. Fonds de la Recherche en Sante du Quebec

向作者/读者索取更多资源

Purpose: Treatments of glioblastoma with cisplatin or oxaliplatin only marginally improve the overall survival of patients and cause important side effects. To prevent adverse effects, improve delivery, and optimize the tumor response to treatment in combination with radiotherapy, a potential approach consists of incorporating the platinum agent in a liposome. Methods and Materials: In this study, cisplatin, oxaliplatin, carboplatin, Lipoplatin (the liposomal formulation of cisplatin), and Lipoxal (the liposomal formulation of oxaliplatin) were tested on F98 glioma orthotopically implanted in Fischer rats. The platinum compounds were administered by intracarotid infusion and were assessed for the ability to reduce toxicity, improve cancer cell uptake, and increase survival of animals when combined or not combined with radiotherapy. Results: The tumor uptake was 2.4-fold more important for Lipoxal than the liposome-free oxaliplatin. Lipoxal also improved the specificity of oxaliplatin as shown by a higher ratio of tumor to right hemisphere uptake. Surprisingly, Lipoplatin led to lower tumor uptake compared with cisplatin. However, Lipoplatin had the advantage of largely reducing the toxicity of cisplatin and allowed us to capitalize on the anticancer activity of this agent. Conclusion: Among the five platinum compounds tested, carboplatin showed the best increase in survival when combined with radiation for treatment of glioma implanted in Fischer rats. (C) 2012 Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Effects of Neuroanatomic Structural Distances on Pituitary Function After Stereotactic Radiosurgery: A Multicenter Study

Natasha Ironside, Ching-Jen Chen, Zhiyuan Xu, David Schlesinger, Mary Lee Vance, Gregory K. Hong, Jr John A. Jane, Samir Patel, Shray K. Bindal, Ajay Niranjan, L. Dade Lunsford, Roman Liscak, Thomas Chytka, Jana Jezkova, Omran Saifi, Daniel M. Trifiletti, Assaf Berger, Juan Alzate, Kenneth Bernstein, Douglas Kondziolka, Herwin Speckter, Wenceslao Hernandez, Erwin Lazo, Selcuk Peker, Yavuz Samanci, Brad E. Zacharia, Christine Mau, Rodney E. Wegner, Matthew J. Shepard, David Mathieu, Michel Maillet, Jason P. Sheehan

Summary: This multicenter study investigated the relationship between neuroanatomic structure distances and anterior pituitary function preservation after stereotactic radiosurgery for pituitary adenomas. The study found that a larger distance between the center of the pituitary stalk and the tumor margin isodose was positively associated with anterior pituitary function preservation. This study provides important insights for preserving pituitary function.

NEUROSURGERY (2023)

Article Clinical Neurology

Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter Study

Georgios Mantziaris, Stylianos Pikis, Zhiyuan Xu, Reed Mullen, Juan Alzate, Kenneth Bernstein, Douglas Kondziolka, Zhishuo Wei, Ajay Niranjan, L. Dade Lunsford, Roman Liscak, Jaromir May, Cheng-chia Lee, Huai-che Yang, Francois-Louis Coupe, David Mathieu, Kimball Sheehan, Darrah Sheehan, Joshua D. Palmer, Haley K. Perlow, Selcuk Peker, Yavuz Samanci, Jennifer Peterson, Daniel M. Trifiletti, Matthew J. Shepard, Shahed Elhamdani, Rodney E. Wegner, Herwin Speckter, Wenceslao Hernandez, Ronald E. Warnick, Jason Sheehan

Summary: This retrospective study showed that stereotactic radiosurgery (SRS) is an effective treatment option for intraventricular metastases (IVMs), with a comparable local control rate to SRS for parenchymal brain metastases. However, careful follow-up is needed to detect leptomeningeal spread and hydrocephalus in patients with IVMs.

NEUROSURGERY (2023)

Article Oncology

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma A Phase 3 Prospective Externally Controlled Cohort Trial

Linda M. Liau, Keyoumars Ashkan, Steven Brem, Jian L. Campian, John E. Trusheim, Fabio M. Iwamoto, David D. Tran, George Ansstas, Charles S. Cobbs, Jason A. Heth, Michael E. Salacz, Stacy D'Andre, Robert D. Aiken, Yaron A. Moshel, Joo Y. Nam, Clement P. Pillainayagam, Stephanie A. Wagner, Kevin A. Walter, Rekha Chaudary, Samuel A. Goldlust, Ian Y. Lee, Daniela A. Bota, Heinrich Elinzano, Jai Grewal, Kevin Lillehei, Tom Mikkelsen, Tobias Walbert, Steven Abram, Andrew J. Brenner, Matthew G. Ewend, Simon Khagi, Darren S. Lovick, Jana Portnow, Lyndon Kim, William G. Loudon, Nina L. Martinez, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Pierre Giglio, Oleg Gligich, Dietmar Krex, Scott M. Lindhorst, Jose Lutzky, Hans-Jorg Meisel, Minou Nadji-Ohl, Lhagva Sanchin, Andrew Sloan, Lynne P. Taylor, Julian K. Wu, Erin M. Dunbar, Arnold B. Etame, Santosh Kesari, David Mathieu, David E. Piccioni, David S. Baskin, Michel Lacroix, Sven-Axel May, Pamela Z. New, Timothy J. Pluard, Steven A. Toms, Victor Tse, Scott Peak, John L. Villano, James D. Battiste, Paul J. Mulholland, Michael L. Pearlman, Kevin Petrecca, Michael Schulder, Robert M. Prins, Alton L. Boynton, Marnix L. Bosch

Summary: The study shows that adding autologous tumor lysate-loaded dendritic cell vaccine (DCVax L) to standard of care can extend the survival of patients with glioblastoma.

JAMA ONCOLOGY (2023)

Article Oncology

Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)

Chad G. Rusthoven, Alyse W. Staley, Dexiang Gao, Shoji Yomo, Denise Bernhardt, Narine Wandrey, Rami El Shafie, Anna Kraemer, Oscar Padilla, Veronica Chiang, Andrew M. Faramand, Joshua D. Palmer, Brad E. Zacharia, Rodney E. Wegner, Jona A. Hattangadi-Gluth, Antonin Levy, Kenneth Bernstein, David Mathieu, Daniel N. Cagney, Michael D. Chan, Inga S. Grills, Steve Braunstein, Cheng-Chia Lee, Jason P. Sheehan, Christien Kluwe, Samir Patel, Lia M. Halasz, Nicolaus Andratschke, Christopher P. Deibert, Vivek Verma, Daniel M. Trifiletti, Christopher P. Cifarelli, Juergen Debus, Stephanie E. Combs, Yasunori Sato, Yoshinori Higuchi, Kyoko Aoyagi, Paul D. Brown, Vida Alami, Ajay Niranjan, L. Dade Lunsford, Douglas Kondziolka, D. Ross Camidge, Brian D. Kavanagh, Tyler P. Robin, Toru Serizawa, Masaaki Yamamoto

Summary: By comparing patients with small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), this study found that SCLC patients had shorter overall survival (OS) after stereotactic radiosurgery (SRS), but the central nervous system (CNS) progression was similar in patients matched on baseline factors. There were no significant differences in neurological mortality, number of lesions at CNS progression, or leptomeningeal progression between SCLC and NSCLC.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Clinical Neurology

Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter Analysis

Raj Singh, Greg Bowden, David Mathieu, Haley K. Perlow, Joshua D. Palmer, Shahed Elhamdani, Matthew Shepard, Yun Liang, Ahmed M. Nabeel, Wael A. Reda, Sameh R. Tawadros, Khaled Abdelkarim, Amr M. N. El-Shehaby, Reem M. Emad, Ahmed Hesham Elazzazi, Ronald E. Warnick, Yair M. Gozal, Megan Daly, Brendan McShane, Marcel Addis-Jackson, Gokul Karthikeyan, Sian Smith, Piero Picozzi, Andrea Franzini, Tehila Kaisman-Elbaz, Huai-che Yang, Zhishuo Wei, Andrew Legarreta, Judith Hess, Kelsey Templeton, Stylianos Pikis, Georgios Mantziaris, Gabriela Simonova, Roman Liscak, Selcuk Peker, Yavuz Samanci, Veronica Chiang, Ajay Niranjan, Charles R. Kersh, Cheng-Chia Lee, Daniel M. Trifiletti, L. Dade Lunsford, Jason P. Sheehan

Summary: Limited data is available regarding outcomes for GI primaries patients with brain metastases treated with SRS. This study aimed to examine the clinical outcomes of SRS for patients with brain metastases from GI primaries and evaluate potential prognostic factors. SRS resulted in comparable LC with common primaries. Age and KPS were associated with both LC and OS, and planning target volume and extracranial metastases were correlated with LC and OS, respectively. These factors should be considered in selecting GI cancer patients for SRS.

NEUROSURGERY (2023)

Article Clinical Neurology

Gamma Knife Stereotactic Radiosurgery for Trigeminal Neuralgia Secondary to Multiple Sclerosis: A Case-Control Study

William Leduc, David Mathieu, Elizabeth Adam, Raphaelle Ferreira, Christian Iorio-Morin

Summary: This study found that SRS is a safe and effective treatment for pain relief in MS-TN. However, the duration of pain relief is significantly shorter compared to a matched control group without MS.

NEUROSURGERY (2023)

Article Clinical Neurology

Stereotactic Radiosurgery for Vestibular Schwannoma in Neurofibromatosis Type 2: An International Multicenter Case Series of Response and Malignant Transformation Risk

Othman Bin-Alamer, Andrew Faramand, Norah A. Alarifi, Zhishuo Wei, Arka N. Mallela, Victor M. Lu, Ahmed M. Nabeel, Wael A. Reda, Sameh R. Tawadros, Khaled Abdelkarim, Amr M. N. El-Shehaby, Reem M. Emad, Selcuk Peker, Yavuz Samanci, Cheng-chia Lee, Huai-che Yang, Violaine Delabar, David Mathieu, Manjul Tripathi, Kathryn Nicole Kearns, Adomas Bunevicius, Jason P. Sheehan, Tomas Chytka, Roman Liscak, Nuria Martinez Moreno, Roberto Martinez Alvarez, Inga S. Grills, Jacob S. Parzen, Christopher P. Cifarelli, Azeem A. Rehman, Herwin Speckter, Ajay Niranjan, L. Dade Lunsford, Hussam Abou-Al-Shaar

Summary: The aim of this study was to evaluate hearing preservation, tumor control, and radiation-related risks in patients with NF2 after SRS for VS. The results showed that the tumor control rate at 15 years after SRS was 52% and no new radiation-related neoplasm or malignant transformation was found in NF2-related VS patients.

NEUROSURGERY (2023)

Article Clinical Neurology

Outcome Evaluation of Repeat Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations

Georgios Mantziaris, Stylianos Pikis, Chloe Dumot, Samantha Dayawansa, Roman Liscak, Jaromir May, Cheng-chia Lee, Huai-che Yang, Nuria Martinez Moreno, Roberto Martinez Alvarez, L. Dade Lunsford, Ajay Niranjan, Zhishuo Wei, Priyanka Srinivasan, Lilly W. W. Tang, Ahmed M. Nabeel, Wael A. Reda, Sameh R. Tawadros, Khaled Abdelkarim, Amr M. N. El-Shehaby, Reem M. Emad, Ahmed Hesham Elazzazi, Selcuk Peker, Yavuz Samanci, Varun Padmanaban, Francis J. Jareczek, James McInerney, Kevin M. Cockroft, David Mathieu, Salman Aldakhil, Juan Diego Alzate, Douglas Kondziolka, Manjul Tripathi, Joshua D. Palmer, Rituraj Upadhyay, Michelle Lin, Gabriel Zada, Cheng Yu, Christopher P. Cifarelli, Daniel T. Cifarelli, Zhiyuan Xu, Jason P. Sheehan

Summary: This study aimed to provide the combined experience of multiple centers to fully define the role of repeat stereotactic radiosurgery (SRS) for patients with cerebral arteriovenous malformation (AVM). The results showed that repeat SRS achieves reasonable obliteration rates with low complication risk. Extending the latency period to 5 years generally increases the rate of favorable patient outcomes and reduces the necessity of a third intervention.

STROKE (2023)

Article Clinical Neurology

Epilepsy associated with cerebral cavernous malformations managed with stereotactic radiosurgery: an international, multicenter study

Chloe Dumot, Georgios Mantziaris, Stylianos Pikis, Sam Dayawansa, Zhiyuan Xu, Yavuz Samanci, Gokce D. Ardor, Selcuk Peker, Ahmed M. Nabeel, Wael A. Reda, Sameh R. Tawadros, Khaled Abdel Karim, Amr M. N. El-Shehaby, Reem M. Emad Eldin, Ahmed H. Elazzazi, Nuria Martinez Moreno, Roberto Martinez alvarez, Roman Liscak, Jaromir May, David Mathieu, Jean-Nicolas Tourigny, Manjul Tripathi, Akshay Rajput, Narendra Kumar, Rupinder Kaur, Piero Picozzi, Andrea Franzini, Herwin Speckter, Wenceslao Hernandez, Anderson Brito, Ronald E. Warnick, Juan Alzate, Douglas Kondziolka, Greg N. Bowden, Samir Patel, Jason P. Sheehan

Summary: Stereotactic radiosurgery (SRS) has been proposed as an alternative to resection for epilepsy control in patients with cerebral cavernous malformations (CCM) located in critical areas. This multicentric, retrospective study evaluated seizure control in patients with a solitary CCM and a history of at least one seizure prior to SRS. 47.7% of patients achieved Engel class I at the last follow-up.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Stereotactic radiosurgery for haemorrhagic cerebral cavernous malformation: a multi-institutional, retrospective study

Chloe Dumot, Georgios Mantziaris, Sam Dayawansa, Zhiyuan Xu, Stylianos Pikis, Selcuk Peker, Yavuz Samanci, Gokce D. Ardor, Ahmed M. Nabeel, Wael A. Reda, Sameh R. Tawadros, Khaled Abdelkarim, Amr M. N. El-Shehaby, Reem M. Eldin, Ahmed H. Elazzazi, Nuria Martinez Moreno, Roberto Martinez Alvarez, Roman Liscak, Jaromir May, David Mathieu, Jean-Nicolas Tourigny, Manjul Tripathi, Akshay Rajput, Narendra Kumar, Rupinder Kaur, Piero Picozzi, Andrea Franzini, Herwin Speckter, Wenceslao Hernandez, Anderson Brito, Ronald E. Warnick, Juan Alzate, Douglas Kondziolka, Greg N. Bowden, Samir Patel, Jason Sheehan

Summary: This retrospective study evaluated the safety and efficacy of single-session stereotactic radiosurgery (SRS) for haemorrhagic cerebral cavernous malformations (CCMs). The results showed that SRS can reduce the haemorrhage rate in CCMs, but may result in adverse radiation effects and new neurological deficits post-treatment. Therefore, selecting appropriate doses and CCM volumes is crucial.

STROKE AND VASCULAR NEUROLOGY (2023)

Article Clinical Neurology

Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancer

Roman O. Kowalchuk, Ajay Niranjan, Judith Hess, Joseph P. Antonios, Michael Y. Zhang, Steve Braunstein, Richard B. Ross, Stylianos Pikis, Christopher P. Deibert, Cheng-chia Lee, Huai-che Yang, Anne-Marie Langlois, David Mathieu, Selcuk Peker, Yavuz Samanci, Chad G. Rusthoven, Veronica Chiang, Zhishuo Wei, L. Dade Lunsford, Daniel M. Trifiletti, Jason P. Sheehan

Summary: This study evaluated the overall survival and local tumor control in a multiinstitutional cohort of patients with triple-negative breast cancer metastases treated with stereotactic radiosurgery (SRS). The findings suggest that SRS is a safe and efficacious treatment for well-selected patients with triple-negative breast cancer who have a favorable performance status and small-to moderate-volume metastatic lesions.

JOURNAL OF NEUROSURGERY (2023)

Article Clinical Neurology

Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients

Eric J. Lehrer, Manmeet S. Ahluwalia, Jason Gurewitz, Kenneth Bernstein, Douglas Kondziolka, Ajay Niranjan, Zhishuo Wei, L. Dade Lunsford, Kareem R. Fakhoury, Chad G. Rusthoven, David Mathieu, Claire Trudel, Timothy D. Malouff, Henry Ruiz-Garcia, Phillip Bonney, Lindsay Hwang, Cheng Yu, Gabriel Zada, Samir Patel, Christopher P. Deibert, Piero Picozzi, Andrea Franzini, Luca Attuati, Rahul N. Prasad, Raju R. Raval, Joshua D. Palmer, Cheng-Chia Lee, Huai-Che Yang, Brianna M. Jones, Sheryl Green, Jason P. Sheehan, Daniel M. Trifiletti

Summary: This retrospective multicenter study investigated the predictors of treatment-related imaging changes (TRICs) and their impact on patient survival in the management of brain metastases using immune checkpoint inhibitors (ICIs) and stereotactic radiosurgery (SRS). The results showed that TRICs were associated with improved overall survival, indicating that the presence of TRICs may increase the survival time of patients after treatment with ICIs and SRS.

JOURNAL OF NEUROSURGERY (2023)

Article Clinical Neurology

Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a multi-institutional study

Stylianos Pikis, Georgios Mantziaris, Rithika Kormath Anand, Ahmed M. Nabeel, Darrah Sheehan, Kimball Sheehan, Wael A. Reda, Sameh R. Tawadros, Khaled Abdelkarim, Amr M. N. El-Shehaby, Reem Emad Eldin, Selcuk Peker, Yavuz Samanci, Tehila Kaisman-Elbaz, Herwin Speckter, Wenceslao Hernandez, Julio Isidor, Manjul Tripathi, Renu Madan, Brad E. Zacharia, Lekhaj C. Daggubati, Nuria Martinez Moreno, Roberto Martinez alvarez, Anne-Marie Langlois, David Mathieu, Christopher P. Deibert, Vivek R. Sudhakar, Christopher P. Cifarelli, Denisse Arteaga Icaza, Daniel T. Cifarelli, Zhishuo Wei, Ajay Niranjan, Gene H. Barnett, L. Dade Lunsford, Greg N. Bowden, Jason P. Sheehan

Summary: In this retrospective multicenter study, the authors evaluated the tumor control and patient outcomes of primary, single-session stereotactic radiosurgery (SRS) treatment for Koos grade IV vestibular schwannomas (VSs). The results showed that single-session SRS treatment is a safe and effective method for obtaining tumor control in patients with non-life-threatening or incapacitating symptoms of Koos grade IV VS. A prescription dose of less than 13 Gy is recommended to reduce the incidence of post-SRS facial palsy.

JOURNAL OF NEUROSURGERY (2023)

Article Clinical Neurology

Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in patients ≥ 65 years old: a multi-institutional retrospective study

Chloe Dumot, Stylianos Pikis, Georgios Mantziaris, Zhiyuan Xu, Sam Dayawansa, Rithika Kormath Anand, Ahmed M. Nabeel, Darrah Sheehan, Kimball Sheehan, Wael A. Reda, Sameh R. Tawadros, Khaled Abdel Karim, Amr M. N. El-Shehaby, Reem M. Emad Eldin, Selcuk Peker, Yavuz Samanci, Tehila Kaisman-Elbaz, Herwin Speckter, Wenceslao Hernandez, Julio Isidor, Manjul Tripathi, Renu Madan, Brad E. Zacharia, Lekhaj C. Daggubati, Nuria Martinez Moreno, Roberto Martinez Alvarez, Anne-Marie Langlois, David Mathieu, Christopher P. Deibert, Vivek R. Sudhakar, Christopher P. Cifarelli, Denisse Arteaga Icaza, Daniel T. Cifarelli, Zhishuo Wei, Ajay Niranjan, Gene H. Barnett, L. Dade Lunsford, Greg N. Bowden, Jason P. Sheehan

Summary: This study aimed to report the clinical and radiological outcomes after single-session stereotactic radiosurgery (SRS) for Koos IV vestibular schwannomas (VS) in patients aged 65 and above. The results showed that SRS had good efficacy in tumor control and cranial nerve function in these patients.

ACTA NEUROCHIRURGICA (2023)

Article Oncology

Response Assessment in Brain Metastases Managed by Stereotactic Radiosurgery: A Reappraisal of the RANO-BM Criteria

Keiss Douri, Christian Iorio-Morin, Rosalie Mercure-Cyr, Gabrielle Figueiredo, Charles Jean Touchette, Laurence Masson-Cote, David Mathieu

Summary: The current RANO-BM criteria are unreliable for identifying tumor progression in patients with brain metastases treated using stereotactic radiosurgery (SRS). Using absolute diameter differences as thresholds appears to be more effective in this cohort.

CURRENT ONCOLOGY (2023)

暂无数据